Research Article
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study
Table 1
Baseline patient and tumor characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||
At diagnosis. 2At MP. 3For 6 patients who progressed on adjuvant therapy, their adjuvant regimen was considered first-line treatment for advanced disease. ECOG: Eastern Cooperative Oncology Group; MP: molecular profiling. |